Matches in Wikidata for { <http://www.wikidata.org/entity/Q81038996> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q81038996 description "artículu científicu espublizáu en setiembre de 2007" @default.
- Q81038996 description "scientific article published on 01 September 2007" @default.
- Q81038996 description "wetenschappelijk artikel" @default.
- Q81038996 description "наукова стаття, опублікована у вересні 2007" @default.
- Q81038996 name "Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers" @default.
- Q81038996 name "Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers" @default.
- Q81038996 type Item @default.
- Q81038996 label "Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers" @default.
- Q81038996 label "Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers" @default.
- Q81038996 prefLabel "Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers" @default.
- Q81038996 prefLabel "Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers" @default.
- Q81038996 P1433 Q81038996-DF7E9FE1-03C1-4B1F-A497-A1642E9CA868 @default.
- Q81038996 P1476 Q81038996-2FBC0693-F3BA-4514-B1F3-8721D8A5C734 @default.
- Q81038996 P2093 Q81038996-36A1182F-8E6A-44F4-B143-370F2EC2B95B @default.
- Q81038996 P2093 Q81038996-40126EA8-EFB7-420E-A947-00C450F5766B @default.
- Q81038996 P2093 Q81038996-48BB79F9-C9F7-41AC-86A2-15ED1B994DA5 @default.
- Q81038996 P2093 Q81038996-5C1CB392-5539-42F0-8BF5-98B2A8E5BDBF @default.
- Q81038996 P2093 Q81038996-867EC076-2ECE-45B4-BDA1-4C1F7DB637C6 @default.
- Q81038996 P2093 Q81038996-E55CD474-9CCA-46FD-9F13-B65CBF0FA98B @default.
- Q81038996 P2093 Q81038996-FD8E7F9A-65C3-431B-A6CC-050253431A23 @default.
- Q81038996 P304 Q81038996-957C34E1-C969-46C6-80DC-C43852D95E6F @default.
- Q81038996 P31 Q81038996-2443F9F4-212F-416F-BB21-A084CF317462 @default.
- Q81038996 P356 Q81038996-3B221F66-883F-4DAB-A898-E6A02A5A022C @default.
- Q81038996 P433 Q81038996-6D813D8E-688D-4DFB-BE13-F2A09DBCB44C @default.
- Q81038996 P478 Q81038996-2EAE12F3-5652-446B-B6AF-6C206C450AAE @default.
- Q81038996 P577 Q81038996-9922CCD8-6CA8-4C97-91A3-E15F73CEABB5 @default.
- Q81038996 P698 Q81038996-C655FB79-7D33-42E8-810D-D47D3B596925 @default.
- Q81038996 P356 1078-0432.CCR-07-0869 @default.
- Q81038996 P698 17785569 @default.
- Q81038996 P1433 Q332253 @default.
- Q81038996 P1476 "Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers" @default.
- Q81038996 P2093 "Ahalya Premkumar" @default.
- Q81038996 P2093 "Hedy Kindler" @default.
- Q81038996 P2093 "Ira Pastan" @default.
- Q81038996 P2093 "Mark C Willingham" @default.
- Q81038996 P2093 "Raffit Hassan" @default.
- Q81038996 P2093 "Robert J Kreitman" @default.
- Q81038996 P2093 "Susie Bullock" @default.
- Q81038996 P304 "5144-5149" @default.
- Q81038996 P31 Q13442814 @default.
- Q81038996 P356 "10.1158/1078-0432.CCR-07-0869" @default.
- Q81038996 P433 "17" @default.
- Q81038996 P478 "13" @default.
- Q81038996 P577 "2007-09-01T00:00:00Z" @default.
- Q81038996 P698 "17785569" @default.